(Q43893957)

English

Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial

scientific article published in January 2012

Statements

Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial (English)
0 references
Erich V de Paula
Silke Ehrenforth
Ampaiwan Chuansumrit
1804 (adept(TM)1) Investigators

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit